Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Vitrous Analysis in Proliferative Diabetic Retinopathy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Anders Kvanta, St. Erik Eye Hospital
ClinicalTrials.gov Identifier:
NCT01478763
First received: November 21, 2011
Last updated: September 24, 2014
Last verified: September 2014

November 21, 2011
September 24, 2014
January 2011
September 2014   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01478763 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Vitrous Analysis in Proliferative Diabetic Retinopathy
Analysis of Vitreous Proteins in Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy

Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy

To analyse and compare vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Vitreous samples

Probability Sample

Patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy

Proliferative Diabetic Retinopathy
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
200
September 2014
September 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • proliferative diabetic retinopathy with vitreous hemorrhage

Exclusion Criteria:

  • vitreous hemorrhage of other cause than proliferative diabetic retinopathy
  • previous vitrectomy
Both
12 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Sweden
 
NCT01478763
Vitreous1
No
Anders Kvanta, St. Erik Eye Hospital
Anders Kvanta
Not Provided
Principal Investigator: Anders Kvanta, PhD St. Erik Eye Hospital
St. Erik Eye Hospital
September 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP